The occurrence of sarcoidosis after treatment of nodal marginal B-cell zone lymphoma in a 56-year-old male: A case report from Syria.
Marginal B-Cells lymphoma
Sarcoidosis
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
12
04
2022
revised:
01
07
2022
accepted:
06
07
2022
entrez:
20
7
2022
pubmed:
21
7
2022
medline:
21
7
2022
Statut:
epublish
Résumé
Sarcoidosis is a chronic systematic inflammatory disorder of unknown etiology. Marginal zone lymphoma is a well-varied family of lymphomas that makes up to 10% of the overall non-Hodgkin's lymphomas. The relationship between sarcoidosis and multiple diseases was mentioned repeatedly in the literature, whereas the relationship between sarcoidosis and marginal zone lymphoma was found rare. This case presents a 56-years-old man who was diagnosed with sarcoidosis after treatment of marginal zone lymphoma. A 56-year-old male presented to Tishreen University Hospital (TUH) Gastrointestinal department with abdominal pain, vomiting, loss of apetite, fever, and unintentional weight loss. Computerized tomography scan of the chest and abdomen, in addition to the excisional biopsy of the cervical nodes, were both highly suggestive of marginal zone lymphoma. After completing a course of chemotherapy, the patient returned with generalized abdominal discomfort, anorexia, and fatigue. Computerized tomography illustrated enlarged mediastinal lymph nodes in the chest and the abdomen. Microscopic examination of an abdominal lymph node revealed granulomatous lymphadenitis with sarcoidosis. Thereafter, the patient was managed with nonsteroidal anti-inflammatory drugs and corticosteroids. We describe the occurrence of sarcoidosis after the treatment of marginal zone lymphoma. In most cases, sarcoidosis precedes lymphomas. This case emphasizes the evidence on the possible relationship between lymphomas and sarcoidosis, and attention should be sought towards any new manifestations throughout the follow-up of patients diagnosed with lymphomas toward sarcoidosis as part of our differential diagnosis.
Identifiants
pubmed: 35855879
doi: 10.1016/j.amsu.2022.104128
pii: S2049-0801(22)00888-3
pmc: PMC9287776
doi:
Types de publication
Case Reports
Langues
eng
Pagination
104128Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors deny any conflict of interest in any terms or by any means during the study.
Références
Curr Oncol Rep. 2018 Mar 23;20(4):33
pubmed: 29572581
Hematology Am Soc Hematol Educ Program. 2012;2012:426-32
pubmed: 23233614
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4428-32
pubmed: 25120829
Korean J Intern Med. 2016 May;31(3):605-7
pubmed: 26968186
Br J Haematol. 2014 Apr;165(1):67-77
pubmed: 24417667
Hematol Oncol Clin North Am. 2008 Oct;22(5):883-901, viii
pubmed: 18954742
Clin Med Insights Case Rep. 2010;3:21-5
pubmed: 21769250
Eur Respir J. 2010 Nov;36(5):1207-9
pubmed: 21037370
J Exp Med. 2006 Feb 20;203(2):359-70
pubmed: 16432251
Hum Pathol. 2016 May;51:57-63
pubmed: 27067783
Int J Surg. 2020 Dec;84:226-230
pubmed: 33181358
Curr Treat Options Oncol. 2019 Dec 5;20(12):90
pubmed: 31807935
J Neurol. 2015;262(4):1035-45
pubmed: 25712543
Medicine (Baltimore). 2014 Nov;93(21):e121
pubmed: 25380084
World Neurosurg. 2019 Feb;122:569-572
pubmed: 30476667